Kruse Bo's Form 4 filing
Y-mAbs Therapeutics, Inc. (YMAB) · filed May 31, 2024
- Accession no.
- 0001104659-24-067356
- Filed
- May 31, 2024
- Trade date
- May 30-31, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $723.1K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kruse BoCIK 0001752940 | Officer (EVP, CFO, SECRY & TREAS.) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | Common Stock | MOption exerciseAcquired | +28,629 | $2.00 | +$57,258 | 239,506 | Direct | |
| May 30, 2024 | Common Stock | SSaleDisposed | −28,629 | $12.03F1 | −$344,406.87 | 210,877 | Direct | |
| May 31, 2024 | Common Stock | MOption exerciseAcquired | +31,371 | $2.00 | +$62,742 | 242,248 | Direct | |
| May 31, 2024 | Common Stock | SSaleDisposed | −31,371 | $12.07F2 | −$378,647.97 | 210,877 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | Common Stock | MOption exerciseDisposed | −28,629 | $0.00 | $0 | 271,371 | Direct | |
| May 31, 2024 | Common Stock | MOption exerciseDisposed | −31,371 | $0.00 | $0 | 240,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $11.85 to $12.22, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $11.87 to $12.42, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.